Smith Jason Drew sold URGN
February 3, 2026 · Form 4 insider transaction
Smith Jason Drew sold 3,217 shares of UroGen Pharma Ltd. at $19.69 per share, a transaction worth $63.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,217
Price
$19.69
Total value
$63.3K
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateFebruary 3, 2026
Filing dateFebruary 11, 2026
Shares owned after55,588
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.